Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

NCT07532824 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)/AML
Proton Therapy
MDS and AML Prior to Allogeneic SCT
Myelodysplastic Neoplasm

Interventions

RADIATION: Proton Total Marrow Irradiation

Sponsor

Institute of Hematology and Blood Transfusion, Czech Republic

Collaborators

[object Object]